Editorial
Published on 03 Nov 2023
Editorial: Multi-omics approaches for decoding heterogeneity in cancer immunotherapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1324212
- 1,458 views
- 2 citations
Type at least 3 characters
551 articles
Articles
Editorial
Published on 27 Oct 2023
Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1307602
- 2,829 views
Brief Research Report
Published on 20 Oct 2023
Pharmacogenomics in clinical trials: an overview
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1247088
- 4,208 views
- 10 citations
Original Research
Published on 19 Oct 2023
Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1292416
- 2,380 views
- 2 citations
Original Research
Published on 17 Oct 2023
Applying machine learning algorithms to develop a survival prediction model for lung adenocarcinoma based on genes related to fatty acid metabolism
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1260742
- 2,633 views
- 1 citation
Original Research
Published on 16 Oct 2023
Comprehensive multi-omics analysis of tryptophan metabolism-related gene expression signature to predict prognosis in gastric cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1267186
- 3,172 views
- 3 citations
Original Research
Published on 28 Sep 2023
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1275833
- 3,042 views
- 3 citations
Original Research
Published on 26 Sep 2023
Decoding tumor heterogeneity in uveal melanoma: basement membrane genes as novel biomarkers and therapeutic targets revealed by multi-omics approaches for cancer immunotherapy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1264345
- 2,885 views
- 3 citations
Original Research
Published on 25 Sep 2023
A disulfidptosis-related lncRNA prognostic model to predict survival and response to immunotherapy in lung adenocarcinoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1254119
- 4,054 views
- 7 citations
Original Research
Published on 25 Sep 2023
A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1280428
- 2,142 views
- 2 citations
Original Research
Published on 20 Sep 2023
Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1267924
- 3,905 views
- 4 citations
Review
Published on 19 Sep 2023
Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1267294
- 5,954 views
- 6 citations
Review
Published on 19 Sep 2023
Redefining the polypill: pros and cons in cardiovascular precision medicine
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1268119
- 4,527 views
- 6 citations
Original Research
Published on 19 Sep 2023
Association between HLA alleles and beta-lactam antibiotics-related severe cutaneous adverse reactions
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1248386
- 2,564 views
- 4 citations
Original Research
Published on 15 Sep 2023
Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1240736
- 2,074 views
- 1 citation
Original Research
Published on 14 Sep 2023
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1248898
- 3,017 views
- 6 citations